resources

Evaluating In Situ Forming Gels for Long-Acting Injectables

Evaluating In Situ Forming Gels for Long-Acting Injectables

Application Notes

Preview - This content has been restricted to logged in users only.

Evaluate in situ forming gels for long-acting injectables with in vitro excipient comparisons to accelerate subcutaneous formulation development.
Evaluating In Situ Forming Gels for Long-Acting Injectables

Application Notes

In situ forming gels provide sustained drug release by transitioning from a liquid to a gel after subcutaneous injection, creating a depot for controlled API delivery. Traditional in vitro methods often fail to accurately predict their performance.

In this study, the SCISSOR™ (Subcutaneous Injection Site Simulator) platform compared five gel formulations of the same small-molecule API within a tissue-mimicking matrix. Using HPLC, imaging, and turbidity analysis over seven days, SCISSOR differentiated release profiles, stability, and gelation behavior, providing mechanistic insights and enabling data-driven selection of optimal formulations for long-acting injectable development.

Previous post